1. Date of resolution: 2026/05/27 2. Directors granted permission: Chairman Chen Chin-tsai, Director Chan Hui-fen 3. Permitted activities: (1) Chen: Corporate representative for Hualian Biotech, Hualian Gene, and Jianzhong Cell Biomedical (2) Chan: Corporate representative for Lewei Ke 4. Duration: During their tenure as ITEQ directors 5. Resolution status: Approved by over two-thirds of voting rights present 6. Mainland China business: Not applicable 7. Financial impact: No material impact 8. Investment: None 9. Other: None.

FACT BOX

  • Source: PR Times
  • Category: corporate_governance